SOPHiA GENETICS Management
Management criteria checks 3/4
SOPHiA GENETICS' CEO is Jurgi Camblong, appointed in Mar 2011, has a tenure of 13.67 years. directly owns 3.7% of the company’s shares, worth $7.80M. The average tenure of the management team and the board of directors is 3.8 years and 4.4 years respectively.
Key information
Jurgi Camblong
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.7yrs |
| CEO ownership | 3.7% |
| Management average tenure | 3.8yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?
Oct 03
SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported, And Analysts Assigned A US$6.00 Price Target
Aug 09Investors Still Waiting For A Pull Back In SOPHiA GENETICS SA (NASDAQ:SOPH)
Aug 08SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 09Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector
Feb 12Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 27Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge
Nov 09Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?
Aug 08Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 15SOPHiA GENETICS partnering with Boundless Bio on oncogene cancer therapies
Sep 21SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M
Aug 09We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely
Jul 01SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 18We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
Mar 10Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Nov 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$71m |
| Jun 30 2024 | n/a | n/a | -US$67m |
| Mar 31 2024 | n/a | n/a | -US$73m |
| Dec 31 2023 | n/a | n/a | -US$79m |
| Sep 30 2023 | n/a | n/a | -US$69m |
| Jun 30 2023 | n/a | n/a | -US$78m |
| Mar 31 2023 | n/a | n/a | -US$82m |
| Dec 31 2022 | US$3m | US$507k | -US$87m |
| Sep 30 2022 | n/a | n/a | -US$95m |
| Jun 30 2022 | n/a | n/a | -US$93m |
| Mar 31 2022 | n/a | n/a | -US$86m |
| Dec 31 2021 | US$8m | US$394k | -US$74m |
Compensation vs Market: Insufficient data to establish whether Jurgi's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Jurgi's compensation has been consistent with company performance over the past year.
CEO
Jurgi Camblong (46 yo)
13.7yrs
Tenure
US$3,332,361
Compensation
Dr. Jurgi Camblong, Ph D., M.B.A., serves as Chief Executive Officer and Director of SOPHiA GENETICS SA since March 2011. Dr. Camblong Co-founded SOPHiA GENETICS SA since March 2011.In 2010, Dr. Camblong...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.7yrs | US$3.33m | 3.7% $ 7.8m | |
| President | no data | no data | 0.093% $ 195.1k | |
| Executive VP & CFO | no data | no data | no data | |
| Senior VP & CTO | 2.8yrs | no data | no data | |
| Executive VP & Chief Scientific Officer | 3.8yrs | no data | 0.62% $ 1.3m | |
| Head of Strategy and Investor Relations | no data | no data | no data | |
| Executive VP | 5.4yrs | no data | 0.14% $ 291.1k | |
| Executive VP & Chief People Officer | 5.8yrs | no data | 0.060% $ 126.5k | |
| VP & MD of EMEA | 1.3yrs | no data | no data | |
| Executive VP | 4.8yrs | no data | 0.063% $ 132.3k |
3.8yrs
Average Tenure
46yo
Average Age
Experienced Management: SOPH's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.7yrs | US$3.33m | 3.7% $ 7.8m | |
| Independent Non-Executive Director | 3.8yrs | US$257.20k | 0.056% $ 118.6k | |
| Independent Non-Executive Director | 4.4yrs | US$265.94k | 0.11% $ 236.2k | |
| Independent Director | 2.8yrs | US$218.17k | 0.095% $ 201.0k | |
| Independent Non-Executive Director | 10.4yrs | US$233.53k | 0.60% $ 1.3m | |
| Independent Non-Executive Director | 3.7yrs | no data | no data | |
| Independent Non-Executive Chairman | 5.4yrs | US$290.93k | 0.28% $ 589.4k |
4.4yrs
Average Tenure
60yo
Average Age
Experienced Board: SOPH's board of directors are considered experienced (4.4 years average tenure).